Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Tesla, TerraForm, and Johnson & Johnson Among the Biggest Weekend Newsmakers

With another quarter almost in the rear-view mirror, many investors are adjusting their portfolios in reaction to the latest news. Of all the potential headlines this week, none is more important than the Fed’s interest rate decision on September 20-21. Rest assured, Insider Monkey will be covering the Fed news and all the associated smart money commentary stemming from it the moment it happens.

In the meantime, let’s take a closer look at five stocks that are making some waves this weekend, which are Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), TerraForm Global Inc (NASDAQ:GLBL), Tesla Motors Inc (NASDAQ:TSLA), and Mobileye NV (NYSE:MBLY). We’ll also use the latest regulatory filing data to see how the smart money is positioned in the five equities.

Hedge fund sentiment is an important metric for assessing the long-term profitability. At Insider Monkey, we track over 750 hedge funds, whose quarterly 13F filings we analyze and determine their collective sentiment towards several thousand stocks. However, our research has shown that the best strategy is to follow hedge funds into their small-cap picks. This approach can allow monthly returns of nearly 95 basis points above the market, as we determined through extensive backtests covering the period between 1999 and 2012 (see the details here).

Tesla Motors Inc (NASDAQ:TSLA), Electric Car, rimac, concept, track, automotive, elegant, brand, design,

Igor Karasi /

M&A in the drug sector is alive and well, as Johnson & Johnson (NYSE:JNJ) recently agreed to buy Abbott Medical Optics from Abbott Laboratories (NYSE:ABT) for $4.325 billion in cash. The acquired division, which produces ophthalmic products for cataract surgery, laser refractive surgery, and consumer eye health, brought in around $1.1 billion in revenue in 2015. Company Group Chairman Ashley McEvoy said:

“With the acquisition of Abbott Medical Optics’ strong and differentiated surgical ophthalmic portfolio, coupled with our world-leading ACUVUE® contact lens business, we will become a more broad-based leader in vision care. Importantly, with this acquisition we will enter cataract surgery – one of the most commonly performed surgeries and the number one cause of preventable blindness.”

The transaction is expected to close in the first quarter of 2017 and would be modestly accretive to adjusted EPS immediately. Ken Fisher‘s Fisher Asset Management reported holding a stake of over 10.8 million shares in Johnson & Johnson (NYSE:JNJ) as of the end of the second quarter, 1% smaller than the number of shares it held the end of the first quarter.

Follow Johnson & Johnson (NYSE:JNJ)
Trade (NYSE:JNJ) Now!

Meanwhile, the smart money tracked by Insider Monkey was growing more optimistic on Abbott from March 31 to June 30. According to our data from 749 13F-filing hedge funds, 47 had a long position in Abbott Laboratories (NYSE:ABT) at the end of the second quarter, up by five quarter-over-quarter.

Follow Abbott Laboratories (NYSE:ABT)
Trade (NYSE:ABT) Now!

Traders are talking about TerraForm Global Inc (NASDAQ:GLBL) after the company provided its preliminary fiscal second quarter 2016 results. For the time period, the company sees production of 605 GWh, revenue of $52 million-to-$56 million, adjusted EBITDA of $40 million-to-$46 million and CAFD of $18 million-to-$24 million. Not many funds in our system were long TerraForm Global at the end of the second quarter, as just 16 owned shares of TerraForm Global Inc (NASDAQ:GLBL) at the end of June, down by seven funds from the end of March.

Follow Terraform Global Inc.
Trade (GLBL) Now!

On the next page, we’ll take a closer look at the latest in the ongoing spat between Tesla and Mobileye.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.